71866 | Outcomes of Transcatheter Aortic Valve Replacement in Patients With and Without Rheumatoid Arthritis: A Propensity Score–Matched Analysis

Abstract

Rheumatoid arthritis (RA) conveys an elevated risk of cardiac valvular disease due to chronic systemic inflammation. Patients with RA undergoing transcatheter aortic valve replacement (TAVR) represent a clinically distinct population. Despite the broad adoption of TAVR in this population, data comparing outcomes between RA and non-RA patients are lacking. We evaluated the safety and effectiveness of TAVR in RA patients compared to matched non-RA patients.